APA

Ly A., Duc H. T., Kalamarides M., Trojan L. A., Pan Y., Shevelev A., François J. C., Noël T., Kane A., Henin D., Anthony D. D. & Trojan J. (20010830). Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma. : Molecular pathology : MP.

Chicago

Ly A, Duc H T, Kalamarides M, Trojan L A, Pan Y, Shevelev A, François J C, Noël T, Kane A, Henin D, Anthony D D and Trojan J. 20010830. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma. : Molecular pathology : MP.

Harvard

Ly A., Duc H. T., Kalamarides M., Trojan L. A., Pan Y., Shevelev A., François J. C., Noël T., Kane A., Henin D., Anthony D. D. and Trojan J. (20010830). Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma. : Molecular pathology : MP.

MLA

Ly A, Duc H T, Kalamarides M, Trojan L A, Pan Y, Shevelev A, François J C, Noël T, Kane A, Henin D, Anthony D D and Trojan J. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma. : Molecular pathology : MP. 20010830.